Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: LEIDOS BIOMEDICAL RESEARCH INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-08-02 to 2024-07-31
Current total value of award: $4417445
Description: PRODUCE SUFFICIENT ADDITIONAL MAB114 DRUG SUBSTANCE (DS) AND DRUG PRODUCT (DP) BATCHES THAT ADHERE TO CGMP COMPLIANCE AND PRODUCT QUALITY RELEASE CRITERIA, AND WHICH MEET THE ANTICIPATED CLINICAL DEMAND FOR ONGOING AND PLANNED CLINICAL TRIALS.